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Azeem Latib, MD, Remo Daniel Covello, MD, Ottavio Alﬁeri, MD, Antonio Colombo, MDC oronary obstruction (CO) is a rare but poten-tially fatal complication in patients undergo-ing transcatheter aortic valve replacementFIGURE 1 Pre-Operative MDCT Findings
(A) Pre-operative multidetector computed tomography (MDCT) showing
with the left main coronary artery (LMCA) ostium (orange arrow). (B) P
mass displaced by the valve implantation (red arrow).
From the San Raffaele Scientiﬁc Institute, Interventional Cardiology Unit, Mil
of Medtronic; and is a consultant for Direct Flow Medical. All other authors ha
to the contents of this paper to disclose.
Manuscript received January 27, 2014; accepted January 30, 2014.(TAVR). CO is most commonly caused by the displace-
ment of a calciﬁed native aortic valve leaﬂet toward
the coronary ostium (1).a heavily calciﬁed aortic valve with a bulky mass in close relationship
ost-operative MDCT showing LMCA ostium subocclusion by calcium
an, Italy. Dr. Latib is a member of the advisory board
ve reported that they have no relationships relevant
FIGURE 2 Steps of TAVR With a Self-Expandable Device in a Patient With Aortic Stenosis and Massive Calciﬁcations
(A to F) Step-by-step implantation of a CoreValve (Medtronic, Minneapolis, Minnesota) 26 mm in a massive calciﬁed aortic valve. After the implantation, the
prosthesis appeared severely distorted, with a mean gradient of 43 mm Hg (C, red arrow); then a balloon post-dilation was performed (D), improving
prosthesis morphology and the mean gradient to 8 mm Hg (E). (F) Final aortic angiography was normal. TAVR ¼ transcatheter aortic valve replacement.
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e106An 89-year-old woman underwent transfemoral
TAVR using a 26-mm CoreValve ReValving System
(Medtronic, Minneapolis, Minnesota). Multidetector
computed tomography (MDCT) scan showed an aortic
annulus of 23  20 mm, a distance from the coronary
ostium of 0.9 cm, and an aortic valve Agatston cal-
cium score of 7,907 (Fig. 1A); calciﬁcations appeared
in close proximity to the left main coronary artery
(LMCA) ostium.
Preparatory balloon aortic valvuloplasty was not
performed because of the extensive calciﬁcations.
Immediately after implantation of the prosthetic
valve, it appeared underexpanded, with a mean
gradient of 43 mm Hg and moderate paraprosthetic
aortic regurgitation (PPAR). Therefore, a 20-mm
balloon post-dilation was performed, reducing
the mean gradient to 8 mm Hg with no evidence
of residual PPAR (Fig. 2D). Final nonselectiveangiographic control demonstrated good coronary
perfusion (Fig. 2F).
Eight hours after the procedure, the patient com-
plained of low-intensity atypical precordial pain.
Electrocardiography showed a new-onset left bundle
branch block, whereas the troponin T level was 1,733
ng/l. No hemodynamic instability was present. Echo-
cardiography revealed an ejection fraction of 25%with
anteroseptal–apical akinesias. Twelve hours later, the
troponin T level rose to 2,268 ng/l. Subsequently,
MDCT angiography was performed that showed sub-
occlusion of the LMCA ostium (Fig. 1B), so the patient
underwent emergency coronary angiography that
conﬁrmed the MDCT scan ﬁndings with severely re-
duced coronary blood ﬂow (Thrombolysis In Myocar-
dial Infarction [TIMI] ﬂow grade 1). In order to
restore LMCA perfusion, a percutaneous coronary
intervention with implantation of a bare-metal stent
FIGURE 3 Treatment of Ostial Left Coronary Occlusion by BMS Placement
(A to D) Initial left main coronary artery (LMCA) angiography showed subocclusion of the ostium (A, red arrow). A pre-dilation was performed ﬁrst (D, E),
then a bare-metal stent (BMS) 3.5  16 mm was implanted (F), and ﬁnally, a balloon post-dilation was performed (G). (H) Final angiographic control showed
good LMCA reperfusion (green arrow).
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e1074.5  16 mm and noncompliant balloon post-dilation
5.0  12 mm at 24 atm was performed. Final selective
LMCA angiography showed Thrombolysis In Myocar-
dial Infarction ﬂow grade 3 (Fig. 3). Despite the excel-
lent angiographic result, the patient followed an
adverse clinical course and died 5 days later.
This case highlights that CO after TAVR is a poten-
tially lethal complication that can sometimes be very
challenging to diagnose. In patients at risk in whomthis complication is suspected, but clinical manifesta-
tions are not clear, MDCT coronary angiography, if
readily available, is a good ﬁrst-line noninvasive test,
followed by urgent intervention if necessary.
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